3 results
To assess the feasibility and safety of endoscopic removal of the Niti-S Esophageal Covered Stent under general anesthesia prior to surgical excision of esophageal cancerous lesions, following an escalating time since placement of the stent of 2…
Primary Objective:- Achieving an event-free survival, which is not inferior to the ML-DS 2006 trial (87±3%)Secondary Objective(s):- Reduction of toxicity: severe adverse events (CTCAE v4.0 grade III or higher)- Evaluation of response- Identification…
Primary objective:•To establish the recommended phase 2 dose of Vyxeos®/CPX-351 in combination with clofarabine in children with relapsed/refractory AML Secondary objectives:•To determine the safety and tolerability of this combination•To determine…